| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 4.12 Billion | USD 17.38 Billion | 17.4% | 2024 |
FrequentlyAsked Questions
The global gene panel market is expected to grow due to rising demand for precision medicine, increasing applications in cancer diagnostics, and advancements in next-generation sequencing (ngs) technologies.
According to a study, the global gene panel market size was worth around USD 4.12 Billion in 2024 and is expected to reach USD 17.38 Billion by 2034.
The global gene panel market is expected to grow at a CAGR of 17.4% during the forecast period.
North America is expected to dominate the gene panel market over the forecast period.
Leading players in the global gene panel market include Agilent Technologies, Thermo Fisher Scientific, Hoffmann-La Roche Ltd, Qiagen, Illumina Inc., BGI Genomics, Integrated DNA Technologies Inc., Genewiz, Novogene Corporation, Personalis Inc., GATC Biotech AG, ArcherDX Inc., GeneDX, Centogene Ag, Invitae Corporation,, among others.
The report explores crucial aspects of the gene panel market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients